AR033671A1 - Composicion farmaceutica acuosa del tipo de gel para administracion subcutanea, procedimiento para su preparacion y el uso de dicha composicion para la preparacion de un medicamento - Google Patents
Composicion farmaceutica acuosa del tipo de gel para administracion subcutanea, procedimiento para su preparacion y el uso de dicha composicion para la preparacion de un medicamentoInfo
- Publication number
- AR033671A1 AR033671A1 ARP010102090A ARP010102090A AR033671A1 AR 033671 A1 AR033671 A1 AR 033671A1 AR P010102090 A ARP010102090 A AR P010102090A AR P010102090 A ARP010102090 A AR P010102090A AR 033671 A1 AR033671 A1 AR 033671A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- pharmaceutical composition
- composition
- subcutaneous administration
- gel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Composición farmacéutica acuosa del tipo de gel para administración subcutánea que comprende ácidos bisfosfónicos o sus sales farmacéuticamente aceptables caracterizada porque la composición farmacéutica tiene por lo menos un compuesto que inhibe la difusión de la sustancia activa en el tejido, estando presente la sustancia activa en forma disuelta en la preparación, y teniendo la preparación una viscosidad de > o = 220 mPa*s, así como también a un procedimiento para la producción de esta preparación. Mediante la preparación es posible administrar localmente concentraciones relativamente elevadas de bisfosfonatos sin que se produzcan incompatibilidades. Uso de dichas composiciones para la preparación de un medicamento.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10021917 | 2000-05-05 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR033671A1 true AR033671A1 (es) | 2004-01-07 |
Family
ID=7640900
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010102090A AR033671A1 (es) | 2000-05-05 | 2001-05-03 | Composicion farmaceutica acuosa del tipo de gel para administracion subcutanea, procedimiento para su preparacion y el uso de dicha composicion para la preparacion de un medicamento |
ARP060103816A AR055407A2 (es) | 2000-05-05 | 2006-08-31 | Composicion farmaceutica acuosa tipo gel para administracion subcutanea, procedimiento para su preparacion y el uso de dicha composicion para la preparacion de un medicamento |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060103816A AR055407A2 (es) | 2000-05-05 | 2006-08-31 | Composicion farmaceutica acuosa tipo gel para administracion subcutanea, procedimiento para su preparacion y el uso de dicha composicion para la preparacion de un medicamento |
Country Status (16)
Country | Link |
---|---|
US (1) | US6676970B2 (es) |
EP (1) | EP1284754B1 (es) |
JP (1) | JP3923800B2 (es) |
KR (1) | KR100492110B1 (es) |
CN (1) | CN1180846C (es) |
AR (2) | AR033671A1 (es) |
AT (1) | ATE314862T1 (es) |
AU (1) | AU778431B2 (es) |
BR (1) | BR0110618A (es) |
CA (1) | CA2407747C (es) |
DE (1) | DE60116483T2 (es) |
DK (1) | DK1284754T3 (es) |
ES (1) | ES2254410T3 (es) |
MX (1) | MXPA02010740A (es) |
WO (1) | WO2001085217A1 (es) |
ZA (1) | ZA200208499B (es) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002062352A2 (en) * | 2001-02-07 | 2002-08-15 | Durect Corporation | Devices and methods for management of bone density |
US7875597B2 (en) * | 2002-07-24 | 2011-01-25 | New York University | Treatment of spinal mechanical pain |
CN100364544C (zh) * | 2004-07-21 | 2008-01-30 | 上海第二医科大学附属瑞金医院 | 一种携带二氯亚甲基二膦酸的明胶微粒及制备方法 |
ATE495747T1 (de) * | 2004-08-23 | 2011-02-15 | Teva Pharma | Kristalline form des ibandronat-natriums und herstellungsverfahren dafür |
US7294195B2 (en) * | 2005-08-08 | 2007-11-13 | Wacker Chemical Corporation | Water repellant gypsum compositions |
ITMI20052515A1 (it) * | 2005-12-29 | 2007-06-30 | Abiogen Pharma Spa | Formulazione farmaceutica per il trattamento della osteoartrite |
AU2007321109A1 (en) * | 2006-11-17 | 2008-05-22 | Besins Healthcare | Liquid pharmaceutical compositions comprising a bisphosphonate compound |
EP1923049A1 (en) * | 2006-11-17 | 2008-05-21 | Besins Healthcare | Pharmaceutical compositions comprising a bisphosphonate compound |
US8974801B2 (en) * | 2006-12-21 | 2015-03-10 | Amphastar Pharmaceuticals Inc. | Long term sustained release pharmaceutical composition containing aqueous suspension of bisphosphonate |
EP1992364A1 (en) * | 2007-05-16 | 2008-11-19 | Biosuma S.r.l. | Carboxylated polysaccharides phosphated or bisphosphonated derivatives, optionally cross-linked, and their preparation and biomedical uses |
US20090311237A1 (en) * | 2008-04-14 | 2009-12-17 | Frost Gregory I | Combination therapy using a soluble hyaluronidase and a bisphosphonate |
US20100247607A1 (en) * | 2009-03-26 | 2010-09-30 | Psivida Us, Inc. | Implantable formulations of bisphosphonic acids |
US20160016982A1 (en) | 2009-07-31 | 2016-01-21 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
US9169279B2 (en) | 2009-07-31 | 2015-10-27 | Thar Pharmaceuticals, Inc. | Crystallization method and bioavailability |
PT2459176T (pt) | 2009-07-31 | 2017-12-11 | Gruenenthal Gmbh | Método de cristalização e biodisponibilidade |
CN102000094B (zh) * | 2010-09-27 | 2013-03-27 | 天津南开允公医药科技有限公司 | 一种含有伊班膦酸的药物组合物及制备工艺 |
US20120089118A1 (en) * | 2010-10-08 | 2012-04-12 | A Nevada Corporation | Delivery of bisphosphonates by microinjection systems |
WO2012071517A2 (en) | 2010-11-24 | 2012-05-31 | Thar Pharmaceuticals, Inc. | Novel crystalline forms |
GB201412236D0 (en) * | 2014-07-09 | 2014-08-20 | Univ Nottingham | Method of producing and using alginate hydrogels |
JP6980360B2 (ja) * | 2014-09-03 | 2021-12-15 | 日東電工株式会社 | ビスホスホネート剤を含む液性免疫用ワクチン医薬組成物 |
US10195218B2 (en) | 2016-05-31 | 2019-02-05 | Grunenthal Gmbh | Crystallization method and bioavailability |
IT201800009444A1 (it) | 2018-10-15 | 2020-04-15 | Fidia Farm Spa | Coniugati tra acido ialuronico e amminobisfosfonati e loro impiego terapeutico |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE61111C (de) | B. WINKLER in Berka a. Werrä | Verfahren zur Herstellung von Knöpfen ohne Fadenbefestigung | ||
US4446052A (en) * | 1982-05-17 | 1984-05-01 | The Procter & Gamble Company | Aqueous gel containing tricalcium di(1-hydroxy-3-aminopropane-1,1-diphosphonate |
DE3512536A1 (de) * | 1985-04-06 | 1986-10-16 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue diphosphonsaeure-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
DE3540150A1 (de) | 1985-11-13 | 1987-05-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
DE3623397A1 (de) | 1986-07-11 | 1988-01-14 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
DE3626058A1 (de) | 1986-08-01 | 1988-02-11 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
DE3640938A1 (de) | 1986-11-29 | 1988-06-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindung enthaltende arzneimittel |
DE3822650A1 (de) | 1988-07-05 | 1990-02-01 | Boehringer Mannheim Gmbh | Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel |
US4922077A (en) | 1989-01-31 | 1990-05-01 | Raytheon Company | Method of laser marking metal packages |
CA2035179C (en) * | 1990-01-31 | 2001-08-14 | Gerald S. Brenner | Pharmaceutical compositions containing insoluble salts of bisphosphonic acids |
DE4223940A1 (de) * | 1992-07-21 | 1994-01-27 | Boehringer Mannheim Gmbh | Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
DE4228552A1 (de) * | 1992-08-27 | 1994-03-03 | Boehringer Mannheim Gmbh | Diphosphonsäuren und deren Salze enthaltende Arzneimittel |
DE4244422A1 (de) | 1992-12-29 | 1994-06-30 | Boehringer Mannheim Gmbh | Schwerlösliche Zink- und Magnesiumsalze von 1,1-Bisphosphonsäuren, ihre Herstellung und Verwendung als Arzneimittel |
DE4244423A1 (de) | 1992-12-29 | 1994-06-30 | Boehringer Mannheim Gmbh | Wasserlösliche Calciumsalze der 1-Hydroxy-3-(methylpentylamino)propan-1,1-bisphosphonsäure, ihre Herstellung und Verwendung als Arzneimittel |
US5780455A (en) * | 1994-08-24 | 1998-07-14 | Merck & Co., Inc. | Intravenous alendronate formulations |
US5652227A (en) * | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
US5994329A (en) * | 1997-07-22 | 1999-11-30 | Merck & Co., Inc. | Method for inhibiting bone resorption |
SE9901272D0 (sv) * | 1999-04-09 | 1999-04-09 | Astra Ab | New improved formulation |
-
2001
- 2001-04-23 EP EP01929595A patent/EP1284754B1/en not_active Expired - Lifetime
- 2001-04-23 JP JP2001581870A patent/JP3923800B2/ja not_active Expired - Lifetime
- 2001-04-23 MX MXPA02010740A patent/MXPA02010740A/es active IP Right Grant
- 2001-04-23 AU AU56317/01A patent/AU778431B2/en not_active Ceased
- 2001-04-23 AT AT01929595T patent/ATE314862T1/de active
- 2001-04-23 DK DK01929595T patent/DK1284754T3/da active
- 2001-04-23 ES ES01929595T patent/ES2254410T3/es not_active Expired - Lifetime
- 2001-04-23 CN CNB018089771A patent/CN1180846C/zh not_active Expired - Fee Related
- 2001-04-23 KR KR10-2002-7014837A patent/KR100492110B1/ko not_active IP Right Cessation
- 2001-04-23 DE DE60116483T patent/DE60116483T2/de not_active Expired - Lifetime
- 2001-04-23 BR BR0110618-0A patent/BR0110618A/pt not_active IP Right Cessation
- 2001-04-23 WO PCT/EP2001/004550 patent/WO2001085217A1/en active IP Right Grant
- 2001-04-23 CA CA002407747A patent/CA2407747C/en not_active Expired - Fee Related
- 2001-05-03 AR ARP010102090A patent/AR033671A1/es not_active Application Discontinuation
- 2001-05-03 US US09/848,638 patent/US6676970B2/en not_active Expired - Lifetime
-
2002
- 2002-10-21 ZA ZA200208499A patent/ZA200208499B/en unknown
-
2006
- 2006-08-31 AR ARP060103816A patent/AR055407A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AU5631701A (en) | 2001-11-20 |
DE60116483D1 (de) | 2006-03-30 |
EP1284754A1 (en) | 2003-02-26 |
ZA200208499B (en) | 2004-02-26 |
CN1180846C (zh) | 2004-12-22 |
AU778431B2 (en) | 2004-12-02 |
BR0110618A (pt) | 2003-04-29 |
US6676970B2 (en) | 2004-01-13 |
DK1284754T3 (da) | 2006-05-01 |
KR100492110B1 (ko) | 2005-06-02 |
ES2254410T3 (es) | 2006-06-16 |
MXPA02010740A (es) | 2003-03-10 |
KR20030009470A (ko) | 2003-01-29 |
JP3923800B2 (ja) | 2007-06-06 |
ATE314862T1 (de) | 2006-02-15 |
DE60116483T2 (de) | 2006-09-07 |
AR055407A2 (es) | 2007-08-22 |
CN1427727A (zh) | 2003-07-02 |
EP1284754B1 (en) | 2006-01-04 |
JP2003532689A (ja) | 2003-11-05 |
US20010053388A1 (en) | 2001-12-20 |
CA2407747A1 (en) | 2001-11-15 |
WO2001085217A1 (en) | 2001-11-15 |
CA2407747C (en) | 2008-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR033671A1 (es) | Composicion farmaceutica acuosa del tipo de gel para administracion subcutanea, procedimiento para su preparacion y el uso de dicha composicion para la preparacion de un medicamento | |
AR037517A1 (es) | Derivados de naftiridinas, un proceso para su preparacion, composicion farmaceutica y el uso de los mismos para la preparacion de un medicamento para el tratamiento de una enfermedad inflamatoria | |
CO6220962A2 (es) | Usos terapeuticos novedosos de 1-[2(2,4-dimetilfenilsulfanil)fenil]-piperazina | |
AR011133A1 (es) | MICROGRÁNULOS DE LIBERACIoN CONTROLADA QUE CONTIENEN CISPLATINO , PROCEDIMIENTO DE SU PREPARACIoN, COMPOSICIoN FARMACÉUTICA Y UTILIZACIoN EN LA FABRICACIoN DE UN MEDICAMENTO POLIQUIMIOTERAPIA O EN ASOCIACIoN CON UNA RADIOTERAPIA. | |
BR0008590A (pt) | Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto | |
AR039744A1 (es) | Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada | |
ES2190244T3 (es) | Uso de la hormona paratiroidea constituida por una secuencia de aminoacidos 1-34 de la hormona paratiroidea humana para reducir el riesco de fracturas oseas vertebrales y no vertebrales. | |
AR025959A1 (es) | DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
AR037560A1 (es) | Formulacion de altas dosis de ibandronato | |
CL2021001810A1 (es) | Combinación de dextrometorfano y bupropión para el tratamiento de depresión | |
AR065580A1 (es) | Mejoras en composiciones medicinales o relativas a las mismas | |
NI200600146A (es) | Composición farmacéutica de vinflunina para administración parenteral, proceso de preparación y su uso | |
ECSP034826A (es) | Método para fabricar una composición farmacéutica de dosis baja | |
KR101344600B1 (ko) | 유방암 및/또는 유선염 치료용 이온토포레시스 제제 | |
JPH0543711B2 (es) | ||
JP2016027036A (ja) | 外用組成物、化粧料、経皮吸収促進用組成物、外用組成物における有効成分の経皮吸収性を高める方法、経皮投与型医薬及び点眼用組成物 | |
UA93365C2 (ru) | Инъекционная форма диклофенака и его фармацевтически приемлемых солей (варианты) и способ его приготовления (варианты) | |
ES2255977T3 (es) | Utilizacion de un compuesto farmaceutico que contiene desoxipeganina para el tratamiento de la dependencia a la nicotina. | |
PE20130782A1 (es) | Composiciones farmaceuticas que consisten de paracetamol y el proceso para la preparacion del mismo | |
WO2016063265A2 (pt) | Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos | |
AR030704A1 (es) | Enantiomero de quinazolina 1,2-anillado, composiciones farmaceuticas que lo comprenden, procedimiento para preparar dichas composiciones, uso de dicho compuesto en la manufactura de medicamentos para inhibir el desarrollo de tumores y procedimiento para la preparacion de dicho compuesto | |
AR036009A1 (es) | Composicion farmaceutica para el tratamiento o prevencion del dolor visceral y los trastornos gastrointestinales que comprenden un compuesto aminoácido biciclico y uso de este ultimo para fabricar dicha composicion farmaceutica | |
AR062894A1 (es) | Formulaciones para administracion terapeutica de hormona de estimulacion del tiroides (ths) | |
AR044831A1 (es) | Forma de administracion inyectable de la flupirtina | |
KR20220116085A (ko) | 후코이단성분이 포함된 마이크로니들 패치 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |